ANUH PHARMA LTD.

Company Profile

ANUH PHARMA LTD. had its IPO on under the ticker symbol ANUHPHR.

The company operates in the sector and industry. ANUH PHARMA LTD. has a staff strength of 0 employees.

Stock update

Shares of ANUH PHARMA LTD. opened at ₹131.5 at the start of the last trading session i.e. 2023-09-13.

The stocks traded within a range of ₹128 - ₹133.85, and closed at ₹128.65.

This is a -3.09% slip from the previous day's closing price.

A total volume of 48,708 shares were traded at the close of the day’s session.

In the last one week, shares of ANUH PHARMA LTD. have slipped by -5.54%.

ANUH PHARMA LTD.'s Key Ratios

ANUH PHARMA LTD. has a market cap of ₹6.82 billion, indicating a price to book ratio of 2.0739 and a price to sales ratio of 0.9365.

In the last 12-months ANUH PHARMA LTD.’s revenue was ₹0 with a gross profit of ₹737.38 million and an EBITDA of ₹0. The EBITDA ratio measures ANUH PHARMA LTD.'s overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, ANUH PHARMA LTD.’s operating margin was 0% while its return on assets stood at 0% with a return of equity of 0%.

In Q1, ANUH PHARMA LTD.’s quarterly earnings growth was a positive 0% while revenue growth was a positive 0%.

ANUH PHARMA LTD.’s PE and PEG Ratio

Forward PE

0

Trailing PE

27.0862

PEG

Its diluted EPS in the last 12-months stands at ₹0 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into ANUH PHARMA LTD.’s profitability.

ANUH PHARMA LTD. stock is trading at a EV to sales ratio of 0.8336 and a EV to EBITDA ratio of 7.4654. Its price to sales ratio in the trailing 12-months stood at 0.9365.

ANUH PHARMA LTD. stock pays annual dividends of ₹2.75 per share, indicating a yield of 2.03% and a payout ratio of 34.75%.

Balance sheet and cash flow metrics

Total Assets

₹4.05 billion

Total Liabilities

₹1.61 billion

Operating Cash Flow

₹0

Capital Expenditure

₹0

Dividend Payout Ratio

34.75%

ANUH PHARMA LTD. ended 2025 with ₹4.05 billion in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹4.05 billion while shareholder equity stood at ₹2.41 billion.

ANUH PHARMA LTD. ended 2025 with ₹0 in deferred long-term liabilities, ₹1.61 billion in other current liabilities, in common stock, ₹1.14 billion in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹19.27 million and cash and short-term investments were ₹0. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.

ANUH PHARMA LTD.’s total current assets stands at ₹3.08 billion while long-term investments were ₹0 and short-term investments were ₹559.78 million. Its net receivables were ₹1.71 billion compared to accounts payable of ₹1.53 billion and inventory worth ₹726.36 million.

In 2025, ANUH PHARMA LTD.'s operating cash flow was ₹0 while its capital expenditure stood at ₹0.

Comparatively, ANUH PHARMA LTD. paid ₹0.35 in dividends in 2025.

Other key metrics

Current Trading Price

₹128.65

52-Week High

₹140.5

52-Week Low

₹75.8346

Analyst Target Price

₹

ANUH PHARMA LTD. stock is currently trading at ₹128.65 per share. It touched a 52-week high of ₹140.5 and a 52-week low of ₹140.5. Analysts tracking the stock have a 12-month average target price of ₹.

Its 50-day moving average was ₹121.44 and 200-day moving average was ₹96.97 The short ratio stood at 0 indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.